Tag: NAFDAC

  • Mary Njoku raises alarm over suspected fake drugs in Nigeria, seeks NAFDAC’s probe

    Mary Njoku raises alarm over suspected fake drugs in Nigeria, seeks NAFDAC’s probe

    Actress and producer Mary Remmy Njoku has urged the National Agency for Food and Drug Administration and Control (NAFDAC) to address the widespread circulation of potentially fake or ineffective medications in Nigeria.

    In a post on Instagram, Njoku recounted her recent experience with food poisoning while on a film set. She said she took medication purchased from a popular pharmacy chain in Nigeria, but after three days, her symptoms remained.

    According to her, after her husband gave her the same drug bought from abroad, she began to feel better within five minutes.

    Njoku noted that the case was not an isolated incident and questioned the quality of medications sold locally.

    She called on NAFDAC to act swiftly, warning that the availability of substandard drugs poses a serious public health threat that must be urgently addressed.

    She said, “I want to share a recent experience: I had food poisoning on a set and sent a staff member to buy Imodium from a well-known pharmacy chain in Nigeria.

    Read Also: Mary Njoku opens up on struggle with uncertainty, self-doubt

    “A medication I’ve used many times before. I took it for about three days, but my symptoms persisted.

    “Then my husband bought a tiny tablet of the same Imodium from abroad, and after taking it, my stomach issues subsided within just five minutes.

    “This isn’t the first time I have noticed a difference. So I have to ask: What exactly are we being sold in Nigeria? What’s going on with our drugs?

    “This is a public health risk, and NAFDAC must take it seriously. This is very dangerous.”

  • Fake drug battle: Community pharmacists back NAFDAC

    Fake drug battle: Community pharmacists back NAFDAC

    • Seek support for local manufacturers

    The Association of Community Pharmacists of Nigeria (ACPN) has thrown its weight behind the regulatory actions being taken by the National Agency for Food and Drug Administration and Control (NAFDAC) to sanitise the pharmacy industry and safeguard the nation’s health. The association called for urgent reforms and government support for local drug manufacturers.

    It expressed concern over the resurgence of fake and substandard medicines in Nigeria.

    The pharmacists said their support for NAFDAC’s enforcement efforts, including the recent closure of the notorious Sabon-Geri drug market in Kano, was informed by a disturbing trend.

    According to internal research by the ACPN, more than 50 per cent of drugs currently circulating in Nigeria may be fake or substandard — figures that are far higher than the official estimate of 13 to 15 per cent.

    ACPN noted that the trend mirrored the crisis levels of the 1990s and demanded a systemic response to halt further deterioration.

    “Almost five million unregistered drug-selling outfits are operating across Nigeria. It is only through strong enforcement partnerships and legal reform that we can protect consumers,” said ACPN National Chairman Ezeh Ambrose Igwekamma, in a statement ACPN issued ahead of its 44th annual international conference, scheduled to be held from July 22 to 27 in Awka, Anambra State.

    Themed: Technology Integration, Personalised Care: The Future of Community Pharmacy Practice, the conference will serve as a rallying point for stakeholders to discuss the modernization of pharmacy practice.

    Igwekamma said the event will focus on adopting cutting-edge technologies, such as artificial intelligence (AI), telepharmacy, point-of-care diagnostics, and electronic health records, to improve pharmaceutical service delivery across communities.

    “Personalised pharmaceutical care must take the centre stage, ensuring that every Nigerian gets tailored, data-driven services from the pharmacy closest to them.

    “Our goal is to shift from reactive to preventive care and restore public confidence in the drug supply chain,” he said.

    In line with this vision, ACPN lauded local pharmaceutical manufacturers for their resilience in the face of operational and regulatory challenges.

    Read Also: Delta community leader warns against sponsored protests against Tantita

    Igwekamma lauded ACPN members’ continued production of essential medicines, despite what he called limited government support, and called for deliberate policy incentives to ease the importation of raw materials and expand local production capacity.

    He said: “Strengthening our pharmaceutical industry is not only about healthcare. It is about national security, job creation, and economic growth.

    “Nigeria must position itself to take full advantage of the African Continental Free Trade Area by becoming a hub for quality pharmaceutical production.”

    The ACPN national chairman urged the National Assembly to urgently amend what he called the outdated Fake Drug and Unwholesome Food Act to reflect current realities and give regulatory agencies more legal backing.

    The collapse of Federal and State Task Forces on fake drugs, the group said, has left gaping holes in the nation’s ability to monitor and secure its pharmaceutical supply chain.

    The upcoming conference in Awka is expected to attract more than 3,000 delegates from within and outside Nigeria, including pharmacists, researchers, policymakers, tech innovators, and healthcare entrepreneurs.

  • Fake drug surge: Community pharmacists back NAFDAC

    Fake drug surge: Community pharmacists back NAFDAC

    …demand reforms, support for local manufacturers

    Amid growing concern over the resurgence of fake and substandard medicines in Nigeria, the Association of Community Pharmacists of Nigeria (ACPN) has thrown its weight behind regulatory actions by the National Agency for Food and Drug Administration and Control (NAFDAC), while calling for urgent reforms and government support for local drug manufacturers.

    The pharmacists say their support for NAFDAC’s enforcement efforts, including the recent closure of the notorious Sabon-Geri drug market in Kano, is driven by a disturbing trend.

    According to internal research by the ACPN, more than 50 percent of drugs currently circulating in Nigeria may be fake or substandard—figures far higher than the official estimate of 13 to 15 percent.

    The group warns that this mirrors the crisis levels of the 1990s and demands a systemic response to halt further deterioration.

    “Almost five million unregistered drug-selling outfits are operating across Nigeria. It is only through strong enforcement partnerships and legal reform that we can protect consumers,” said ACPN National Chairman, Pharm. Ezeh Ambrose Igwekamma, in a statement ahead of the association’s 44th Annual International Conference, scheduled to take place from July 22 to 27 in Awka, Anambra State.

    Themed ‘Technology Integration, Personalized Care: The Future of Community Pharmacy Practice’, the conference will serve as a rallying point for stakeholders to discuss the modernization of pharmacy practice.

    Igwekamma said the event will focus on adopting cutting-edge technologies such as artificial intelligence, telepharmacy, point-of-care diagnostics, and electronic health records to improve pharmaceutical service delivery across communities.

    “Personalised pharmaceutical care must take centre stage, ensuring that every Nigerian gets tailored, data-driven services from the pharmacy closest to them.

    “Our goal is to shift from reactive to preventive care and restore public confidence in the drug supply chain,” he said.

    In line with this vision, ACPN also lauded local pharmaceutical manufacturers for their resilience in the face of operational and regulatory challenges.

    Read Also: Tinubu mandated us to complete 27.1km Bonny Ring Road, says NDDC

    Igwekamma commended their continued production of essential medicines, even with limited government support, and called for deliberate policy incentives to ease the importation of raw materials and expand local production capacity.

    He said: “Strengthening our pharmaceutical industry is not only about healthcare. It is about national security, job creation, and economic growth.

    “Nigeria must position itself to take full advantage of the African Continental Free Trade Area by becoming a hub for quality pharmaceutical production.”

    The ACPN urged the National Assembly to urgently amend the outdated Fake Drug and Unwholesome Food Act to reflect current realities and give regulatory agencies more legal backing.

    The collapse of Federal and State Task Forces on fake drugs, the group said, has left gaping holes in the nation’s ability to monitor and secure its pharmaceutical supply chain.

    The upcoming conference in Awka is expected to attract more than 3,000 delegates from within and outside Nigeria, including pharmacists, researchers, policymakers, tech innovators, and healthcare entrepreneurs.

    Highlights will include a symbolic walk against counterfeit medicines, technical sessions on regulatory reform and digital health, and an exhibition of pharmaceutical and health-tech innovations.

    “The government of Anambra State has shown remarkable support, and we believe Awka will offer the right environment for dialogue and action.

    “Together, we must build a pharmacy model that delivers impact through innovation, compassion, and community engagement,” Igwekamma said.

  • NAFDAC bans counterfeit batch of antibiotic drug

    NAFDAC bans counterfeit batch of antibiotic drug

    The National Agency for Food and Drug Administration and Control (NAFDAC) has banned an unregistered batch of Tarivid (Ofloxacin 200mg), a widely used antibacterial medication.

    The agency said the World Health Organisation (WHO) Global Surveillance and Monitoring System (GSMS) would be informed of the ban to have it flagged internationally as a counterfeit medication.

    In its public alert numbered 21/2025, titled ‘Alert on the Report of Unregistered Tarivid (Ofloxacin 200mg) found in Nigeria’ and released on Tuesday,  NAFDAC stated that the product was found on the shelf of a pharmacy in   Onipan,   Shomolu Local Government Area of  Lagos State.

    Tarivid, manufactured by a global pharmaceutical company, Sanofi,  is a brand of Ofloxacin, a broad-spectrum antibacterial agent used in the treatment of respiratory tract, urinary tract, kidneys, skin, and soft tissue infections.

    Read Also: NAFDAC will not bow to pressure — D-G Adeyeye

    The unregistered product was manufactured in   September 2023. Its expiry date is August 2028.

    According to the agency, a representative of Sanofi claimed that the identified batch was originally manufactured for distribution in Pakistan. It said the conclusion was backed by a review conducted at Sanofi’s Anti-Falsified and Illicit Trafficking (AFIT) Central Laboratory.

    The batch, according to NAFDAC, falls outside the scope of products registered and approved for circulation in Nigeria.

    The agency stated that by not complying with regulatory provisions, the safety, quality, and efficacy of such products are not guaranteed.

  • NAFDAC flags, bans counterfeit batch of Tarivid antibiotic

    NAFDAC flags, bans counterfeit batch of Tarivid antibiotic

    The National Agency for Food and Drug Administration and Control (NAFDAC) has banned an unregistered batch of Tarivid (Ofloxacin 200mg), a widely used antibacterial medication, after it was discovered circulating within Nigeria’s healthcare supply chain.

    The agency stated that the alert will be uploaded to the World Health Organization (WHO) Global Surveillance and Monitoring System (GSMS) to support international tracking of the counterfeit batch.

    In its public alert numbered 21/2025, titled ‘Alert on the Report of Unregistered Tarivid (Ofloxacin 200mg) found in Nigeria’ and released on Tuesday, June 10, 2025, the agency disclosed that the banned product was found on the shelf during a routine surveillance operation in the Onipan area of Shomolu Local Government Area, Lagos State.

    Tarivid, manufactured by global pharmaceutical company Sanofi, is a brand of Ofloxacin, a broad-spectrum antibacterial agent used in the treatment of various infections including those of the respiratory tract, urinary tract, kidneys, skin, and soft tissues.

    The unregistered product is identified as Tarivid (Ofloxacin 200mg), manufactured by Sanofi, with a manufacturing date of September 2023 and an expiry date of August 2028. 

    The stated NAFDAC Registration Number (NRN) on the product is AL016.

    According to the alert, NAFDAC’s Post-Marketing Surveillance Directorate made the discovery during a market monitoring exercise. 

    Following this, the agency’s investigation confirmed that the product batch in question was never intended for the Nigerian market.

    Read Also: Group demands refund of over N3bn allegedly collected by NAFDAC from Onitsha drug market traders

    According to the agency, a representative of Sanofi, the product’s Marketing Authorization Holder, clarified that the identified batch was originally manufactured for distribution in Pakistan. 

    It said the conclusion was backed by a review conducted at Sanofi’s Anti-Falsified and Illicit Trafficking (AFIT) Central Laboratory. 

    The batch, according to NAFDAC, falls outside the scope of products registered and approved for circulation in Nigeria.

    The agency stated that by not complying with regulatory provisions, the safety, quality, and efficacy of such products are not guaranteed.

    NAFDAC warned that the distribution and sale of unregistered medical products such as this pose significant health risks. 

    In response to the discovery, NAFDAC has directed all zonal directors and state coordinators to intensify surveillance and conduct a mop-up operation to remove the counterfeit batch from circulation across the country.

    Distributors, retailers, healthcare professionals, and caregivers have been urged to exercise extreme caution and maintain vigilance across the pharmaceutical supply chain. 

    The agency emphasized the importance of sourcing medicines from authorized and licensed suppliers and conducting proper verification of product authenticity and physical condition.

    NAFDAC is encouraging healthcare professionals and the public to report any suspected cases of substandard or falsified medicines to the nearest NAFDAC office. 

    In addition, it said adverse reactions or side effects linked to medical products can be reported through the e-reporting platforms on the NAFDAC website.

  • Group demands refund of over N3bn allegedly collected by NAFDAC from Onitsha drug market traders

    Group demands refund of over N3bn allegedly collected by NAFDAC from Onitsha drug market traders

    A civil society group, the International Society for Civil Liberties and Rule of Law (Intersociety), has demanded immediate refund of over N3 billion allegedly collected from traders at the Onitsha Drug Market by the National Agency for Food, Drug Administration and Control (NAFDAC).

    It could be recalled that the market has been shut since February this year following an operation by NAFDAC.

    But there has been outcry that the agency is collecting N700,000 from each of the affected shop owners numbering over 3000.

    Justifying the payment, NAFDAC said the N700,000 was a reduced fine for infractions committed by the traders, adding that the fine was reduced from N7 million to N700,000.

    However, in a statement issued on Friday by Intersociety, the group asked NAFDAC to refund the money.

    The statement was signed by Mr Emeka Umeagbalasi, Head, Intersociety, Chinwe Umeche, Human Rights Lawyer/Head, Democracy and Good Governance, and Chidinma Evangeline Udegbunam, Head, Religious Freedom and Human Rights.

    Read Also: INEC fixes June 20, Aug. 8 for 2026 Ekiti, Osun guber polls

    The organisation said such a refund “must be attached with 20% interest. We also understand that between 3,500 and 3,800 affected traders have been forced to pay as of Thursday, May 29, 2025, according to sources linked to the Market.

    “We are bold to say that no number of excuses or policy defense and sanctification can justify such imposition and forceful collection from traders that have been kept out of their legitimate businesses for more than 90 days.

    “It is also our insistence that we are steadily in solidarity with over 90% of the traders in the Market who are genuine drug traders including those trading on pharmaceutically produced and supplied products and lifesaving and body system supplement drugs. We are also in no way in support of those trading on expired, counterfeit, substandard and fake drugs or products.”

  • NAFDAC will not bow to pressure — D-G Adeyeye

    NAFDAC will not bow to pressure — D-G Adeyeye

    The National Agency for Food and Drug Administration and Control (NAFDAC) on Friday said the agency will not bow to any pressure in its bid to rid the country of banned, counterfeit, unregistered and harmful drugs.

    The Director-General of NAFDAC, Prof. Mojisola Adeyeye made this known at a news conference in Lagos while reacting to claims that the agency forced some traders to pay ₦700,000 for a service they were unaware of.

    She said NAFDAC recent enforcement operation in Idumota, Aba and Onitsha open drug market where harmful and banned drugs worth over one trillion Naira were evacuated was a measure taken by the agency to safeguard the health of the nation.

    She said the charges imposed on the traders are investigative charges which were reduced from N5 million to N200,000 for sales of unregistered drugs and N2million to N500,000 for violation of storage after rigorous consultation.

    The D-G said over 2500 traders with 3500 shops have resumed their normal activity in Ogbogwu market in Onitsha after paying the investigative charges and evacuation of drugs that contravene NAFDAC regulations were removed from the shops.

    She said that NAFDAC’s decision to seal shops and imposed investigative charges followed due process.

    “The charges are Federal government gazetted charges and payments.

    “The agency will not cave in to pressure and there will not be unconstitutional opening of any shops that are yet to comply with NAFDAC directives.

    Read Also: NAFDAC rejects VDM’s ₦.7m traders’ extortion claim 

    “We will not close our eyes to these evil acts that have killed thousands of innocent children and women that died due to fake and substandard medicines,” she said.

    Adeyeye said those spreading propaganda against the agency are done traders who brought banned narcotics to the country and are not ready to abide by the rules of the land.

    She urged Nigerians not to politicise the issue, adding that the agency will continue to take measures that would be in the best interest of the nation.

    Adeyeye assured Nigerians that the agency will continue to work within the purview of it mandate to safeguard the nation’s health.

    (NAN)

  • NAFDAC rejects VDM’s ₦.7m traders’ extortion claim 

    NAFDAC rejects VDM’s ₦.7m traders’ extortion claim 

    …alerts security agencies over possible Cybercrime law violation

    The National Agency for Food and Drug Administration and Control (NAFDAC) has firmly rejected claims made by social media influencer, Very Dark Man (VDM), accusing the agency of extortion in its regulatory enforcement at Onitsha Bridge Head Market. 

    In a rejoinder on Tuesday, the agency described VDM’s comments as inciting and potentially in violation of the Cybercrime Act, stating that it has reported the matter to relevant security agencies for investigation.

    VDM, in a widely circulated Instagram video surrounded by protesting traders, alleged that NAFDAC extorted ₦700,000 from the traders for a service they were unaware of. 

    He displayed a document he claimed was a receipt for the payment and threatened legal action. 

    In response, NAFDAC clarified that the penalties imposed on traders followed due process and were in line with gazetted federal regulations. 

    The agency explained that during recent enforcement operations in three open drug markets, all inspected shops, warehouses, and stores were found to be in violation of Good Storage and Distribution Practices. 

    More critically, none of the premises were registered with the Pharmacy Council of Nigeria (PCN), a clear breach of federal laws.

    Regarding the controversial fees, the agency disclosed that an investigative charge of ₦5 million was imposed on those selling unregistered products, which was later reduced to ₦200,000 after pleas. 

    Similarly, a ₦2 million charge for violating storage standards was reduced to ₦500,000. “These are Federal Government-gazetted charges and payments,” NAFDAC stated, dismissing allegations of theft as baseless and misleading.

    In a statement earlier on Monday, NAFDAC’s Director General, Prof. Mojisola Adeyeye, had warned that VDM’s video amounted to incitement, potentially constituting a breach of the Cybercrime Act. 

    Read Also: NAFDAC warns against incitement by social media influencer VDM

    She emphasized that the influencer’s call for traders to defy regulatory action undermines the authority of NAFDAC and could endanger public health.

    “What this perpetrator has done is to openly tell his audience to defy the regulatory processes of NAFDAC,” Prof. Adeyeye said, noting that the enforcement was carried out under the authority of the Office of the National Security Adviser (ONSA).

    Although the agency was initially silent on the specific ₦700,000 payment mentioned by VDM, it offered a detailed breakdown and justification for the charges on Tuesday, stressing that all actions were lawful and necessary to maintain drug safety standards.

    NAFDAC urged the public to disregard misinformation and reaffirmed its commitment to protecting public health through strict enforcement of regulatory standards, “NAFDAC is working firmly within the purview of her mandate”, the DG said.

    The agency said it would leave it to security and legal authorities to determine if the influencer’s actions violate any statutes under the Cybercrime Act.

    Reaffirming NAFDAC’s mission, the DG said, “We remain committed to ensuring that all medical products, medicines, vaccines, medical devices, and more used in Nigeria are of good quality, safe, and effective. 

    “These efforts are vital in reducing maternal and child mortality, improving life expectancy, and protecting citizens with chronic illnesses such as hypertension and diabetes”.

  • NAFDAC raids fake drug factory in Delta 

    NAFDAC raids fake drug factory in Delta 

    The National Agency For Food and Drug Administration and Control (NAFDAC) has raided a three storey uncompleted building at Azagba Ogwashi near Issele-Azagba, Aniocha South LGA in Delta where illicit drugs and injectables vials are produced.

    The uncompleted building which belongs to a notorious fake drug dealer, Ekene Igwe Emmanuel, serves as factory and residential apartment for his family.

    The agency enforcement team, who led reporters to the scene, arrested one Blessing Igwe, wife of the prime suspect, who is at large and two other occupants.

    NAFDAC Head of the team, Babatunji Omoyeni, Deputy Director, Investigation and Enforcement of Federal Taskforce for South South and South East, said that the agency had successfully tracked a drug shop at Ogbo-Ogu Bridge Head market, in Onitsha where illicit drugs were sold.

    Omoyemi said items recovered, included a big drum containing thousands of vials soaked in liquid substance , adulterated and expired drugs, including large quantities of chloroquine phosphate 322 mg/5ml, petazine injection 50mg//2ml, gentamycin injection 280mg/2ml and many other contraband injectables with new labels.

    He said efforts were being made to track the prime suspect, adding that Blessing Igwe, wife of the culprit would be arraigned in court for trial.

    Read Also: NAFDAC warns against incitement by social media influencer VDM

    NAFDAC Director for South East Zone, Dr Martins Iluyomade said the plans is on to seize the storey building.

    Iluyomade said, ”I feel very said for our country, and the kind of things that are playing out. Only God knows how many people have died from consumption of the illicit drugs produced by these merchants who are looking for money at all cost, and perpetrating these heinous crimes using all manners of avenue including inciting the public against what NAFDAC is doing; using ill gotten money after killing a lot of people. Nigerians need to be very vigilant”

    ”The prime suspect at large is one of the major traders at Ogbo-Ogu Bridge Head drug market in Onitsha whom has been in this illicit drug business. What these drug merchants have done since they knew that Ogbo- Ogu market is no longer safe for their illicit drug business, they have moved out to neighbouring palaces like Asaba in uncompleted buildings, relabelling injectables that expired far back 7 years ago”

    Iluyomade said the drug dealer arbitrarily labelled the vials after cleaning off the original information including expiry dates etc.

    He said, “They use a chemical to clean off the original information on the injectables and then label them as they want and sell to the public who does not know that it is death that is being sold it. If you are trying to treat an illness and you are administered this drug, number one, it is wrongly labeled because what is inside is not what is labeled on it. Secondly, the original product has expired which might be promethazine but he’s labeling it as anti-malaria. Or the original product can be chloroquine and it is labeled as very expensive antibiotic, so you don’t even know what is inside the injectable you are taking”.

  • NAFDAC warns against incitement by social media influencer VDM

    NAFDAC warns against incitement by social media influencer VDM

    The National Agency for Food and Drug Administration and Control (NAFDAC) has strongly condemned what it described as inciting and misleading statements made by a social media influencer targeting the federal hovernment’s regulatory enforcement at the Onitsha Bridge Head Market.

    The agency maintained that it would allow security agencies to carry out their duties regarding the role played by social media influencer, Very Dark Man (VDM), who accused it of extortion and theft. 

    VDM had alleged that the agency forced some traders to pay ₦700,000 for a service they were unaware of. 

    He also threatened legal action in the video shared on Instablog9ja’s Instagram page.

    However, while urging law-abiding Nigerians to continue with their legitimate businesses, the Director General (DG), Prof. Mojisola Adeyeye specifically addressed the role of the social media influencer, saying, What this perpetrator has done is to openly tell his audience to defy the regulatory processes of NAFDAC.

    “This follows an enforcement operation carried out under the authority of the Office of the National Security Adviser.”

    She said NAFDAC will leave it to law enforcement to determine whether the individual has violated any statutes, especially those related to incitement through digital content.

    In a statement on Monday, the DG warned that the content of trending videos by the said influencer, which seek to incite traders at the market against lawful government action, could potentially constitute a breach of the Cybercrime Act.

    She was silent on the N700,000 fee the alleged traders were made to pay to the agency 

    The DG, however, noted that her agency has consequently alerted the public and security agencies to the nature and implications of such incitement.

    She recalled the Agency’s recent enforcement actions at three major Open Drug Markets across the country, Idumota (Lagos), Ariaria (Aba), and Bridge Head (Onitsha) where coordinated operations were carried out between February 9 and March 27, 2025, that led to the seizure and destruction of banned, expired, falsified, and substandard narcotic drugs valued at over ₦1 trillion.

    “These were unregistered, diverted donation drugs, illicit narcotics, and controlled substances stored and distributed in environments that failed to meet even the minimum requirements of Good Storage and Distribution Practices. 

    “More critically, these premises were unregistered with the Pharmacy Council of Nigeria (PCN), in clear contravention of extant federal laws,” she said.

    She also emphasized that NAFDAC’s enforcement role is grounded in its mandate as defined by the Act establishing the Agency which includes regulation and control over the importation, exportation, manufacture, advertisement, distribution, sale, and use of regulated products, ranging from drugs and food to cosmetics, medical devices, packaged water, and chemicals.

    Read Also: Senate summons NAFDAC over use of harmful chemicals to ripen fruits by traders in Nigeria

    “As part of this mandate, we conduct routine inspections of production, distribution, and sales outlets of regulated products, as well as post-approval surveillance.

    “Our operations are also intelligence-driven, responding to petitions, reports, and complaints from the public,” the DG noted.

    She also reminded the public that the Counterfeit and Fake Drugs and Unwholesome Processed Foods Act (C34) expressly prohibits the sale of drugs in markets, kiosks, motor parks, roadside stalls, and in vehicles, noting that based on this law, its enforcement action at Bridge Head Market was justified and necessary.

    According to Adeyeye, due to interventions by state governments, a moratorium was granted to traders to relocate to a Coordinated Wholesale Centre with proper infrastructure for regulated activities. 

    “The market was reopened on March 9, 2025, and over 2,500 traders occupying 3,500 shops have resumed operations, having complied with the necessary regulatory procedures,” she said.

    Clarifying that only a minority of shop owners, those dealing in outrightly banned narcotics have refused to comply, the DG explained that, “According to our database, these defaulters are at the heart of the cartel, and along with their co-conspirators, are now attempting to stoke unrest and shift attention from their crimes.

    “These merchants of death, who are fueling insecurity and trafficking in fake medicines, will be identified and prosecuted.

    Reaffirming NAFDAC’s mission, the DG said, “We remain committed to ensuring that all medical products, medicines, vaccines, medical devices, and more used in Nigeria are of good quality, safe, and effective. 

    “These efforts are vital in reducing maternal and child mortality, improving life expectancy, and protecting citizens with chronic illnesses such as hypertension and diabetes.”

    “NAFDAC is working firmly within the purview of her mandate”.